Clinical Trials on Anemia Ferropenic in Netherlands

Total 128 results

Maastricht University Medical Center
Vifor Pharma

Terminated

The Use of Iron Therapy for Patients With Anemia After Caesarean Section (VITAPOP)

Postoperative Anaemia

Netherlands
Bioverativ, a Sanofi company

Active, not recruiting

Safety and Tolerability Study in Adults With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088

Autoimmune Haemolytic Anaemia

Netherlands, Germany, Italy, Norway, United Kingdom
Bioverativ, a Sanofi company

Completed

A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin Disease

Autoimmune Haemolytic Anaemia

United States, Germany, Italy, Netherlands, Norway, United Kingdom
European Society for Blood and Marrow Transplantation
CHUGAI sanofi-aventis

Terminated

Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF) (SAA-G-CSF)

Aplastic Anaemia

France, Netherlands, Germany, United Kingdom, Switzerland, Italy, Sweden, Greece, Czechia
dr. P. Noordzij
Pharmacosmos A/S

Recruiting

Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients (AGE-ANEMIA)

Iron Deficiency Anemia

Netherlands
Martini Hospital Groningen
dr. J.M. Munster, gynaecologist, principal investigator

Recruiting

The Efficacy of Intermittent Versus Daily Oral Iron Supplementation in Anaemic Pregnant Women. (FER-IDIP)

Pregnancy Related | Iron Deficiency Anemia

Netherlands
Pfizer

Completed

A GBT021601 ADME Microtracer Study in Healthy Volunteers

Sickle Cell Disease

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Adding Azathioprine/Hydroxyurea Preconditioning to Alemtuzumab/TBI to Reduce Risk of Graft Failure in MSD HSCT in Adult SCD Patients

Sickle Cell Disease

Netherlands
Sanquin Research & Blood Bank Divisions
Radboud University Medical Center; Maastricht University Medical Center; UMC... and other collaborators

Recruiting

Data Registry of Auto Immune Hemolytic Anemia (DRAIHA)

Autoimmune Hemolytic Anemia

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD (PROTECT)

Sickle Cell Disease

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
Leiden University Medical Center

Recruiting

Do Alemtuzumab Levels Predict T Cell Chimerism After MSD SCT for SCD? (PREDICT)

Sickle Cell Disease

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Cerebrovascular Reserve Measurements in Sickle Cell Disease (CRUISE)

Sickle Cell Disease

Netherlands
Catharina Ziekenhuis Eindhoven

Terminated

Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery

Anemia, Iron-Deficiency | Heart; Dysfunction Postoperative, Cardiac Surgery

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Low Dose Iron Chelation as TReatment of Oxidative Damage in Sickle Cell Disease (TROS)

Sickle Cell Disease

Netherlands
University Medical Center Groningen
Dutch Kidney Foundation; Vifor Fresenius Medical Care Renal Pharma

Active, not recruiting

Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation (EFFECT-KTx)

Iron-deficiency | Transplant-Related Disorder

Netherlands
Deventer Ziekenhuis

Not yet recruiting

Effect of Postural Change on Hemoglobin Level in Patients on the Intensive Care Unit

Anemia

Netherlands
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion...

Completed

Mortality After Transfusion of Ever-pregnant Donor Red Blood Cells (MATER)

Anemia

Netherlands
Vifor Pharma

Completed

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure (EFFECT-HF)

Chronic Heart Failure | Iron Deficiency

Netherlands
Dr. Marjon H. Cnossen MD PhD
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Recruiting

Brain Structure and Neurocognitive Development in Sickle Cell Disease; a Longitudinal Cohort Study (BRICK Study) (BRICK)

Sickle Cell Disease | Brain Development Abnormality

Netherlands
Rijnstate Hospital

Completed

Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass (Ironsuppletion)

Iron Deficiency

Netherlands
Vifor Pharma
ICON Clinical Research; American Regent, Inc.

Completed

Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (FIND-CKD)

Chronic Kidney Disease | Iron Deficiency Anaemia

United Kingdom, United States, Australia, Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, Turkey
University Medical Center Groningen

Enrolling by invitation

Oxidative Skeletal Muscle Metabolism in Chronic Heart Failure Patients With and Without Iron Deficiency (FERRIFY)

Iron-deficiency | HF - Heart Failure

Netherlands
Vifor Pharma
Socar Research SA

Terminated

EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure (EFFICACY-HF)

Chronic Heart Failure | Iron Deficiency Anemia | Iron Deficiency | Anaemia

France, Netherlands, Denmark, Germany, Israel
Sanquin Research & Blood Bank Divisions
Radboud University Medical Center; Erasmus Medical Center; Academisch Medisch... and other collaborators

Unknown

Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics (STARRING)

Sickle Cell Disease | Alloimmunization

Netherlands
Dong-A ST Co., Ltd.

Completed

A Study in Healthy Volunteers to Compare the Profiles of DA-3880 and EU Sourced ARANESP® (Amgen)

Symptomatic Anemia

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

The Role of Red Cell Characteristics, Angiogenesis, Viscosity and Oxygenation in the Pathophysiology of Sickle Cell Related Retinopathy (RAVOS)

Sickle Cell Disease | Sickle Cell SC Disease | Sickle Cell-SS Disease | Sickle Cell Retinopathy

Netherlands
Maastricht University Medical Center

Recruiting

Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium (COMPETE)

Thrombotic Microangiopathies | Hemolytic-Uremic Syndrome | Hemolytic Uremic Syndrome, Atypical

Netherlands
Radboud University Medical Center

Unknown

The Immunomodulatory Effects of Phlebotomy

Anemia

Netherlands
Hospital Universitari Vall d'Hebron Research Institute

Active, not recruiting

GenoMed4ALL: Improving SCD Classification and Prognosis by AI (GenoMed4ALL)

Sickle Cell Disorders

Spain, Netherlands, France, Italy
Leiden University Medical Center
Radboud University Medical Center; University Medical Center Groningen; Maastricht... and other collaborators

Recruiting

Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease (PRIme)

Inflammatory Bowel Diseases | Iron-deficiency | Iron Deficiency Anemia

Netherlands
Prothya Biosolutions

Terminated

Apotransferrin in Patients With β-thalassemia

β-thalassemia Intermedia

Netherlands
GlaxoSmithKline

Recruiting

Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P) (ASCEND-P)

Anaemia

United States, Italy, Spain, France, United Kingdom, Korea, Republic of, Netherlands, Japan, Argentina, Belgium, Turkey
Maastricht University Medical Center

Completed

The Change in RetHe - Levels Perioperatively in a Cohort of Colorectal Surgery Patient

Anemia | Colorectal Surgery | Perioperative

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
University Medical Center Groningen; Erasmus Medical Center; Guy's and St Thomas... and other collaborators

Completed

N-Acetylcysteine in Patients With Sickle Cell Disease (NAC)

Sickle Cell Disease

Belgium, Netherlands, United Kingdom
Agios Pharmaceuticals, Inc.

Completed

Pyruvate Kinase Deficiency Global Longitudinal Registry Substudy of Protocol AG348-C-008

Pyruvate Kinase Deficiency

United States, Italy, Netherlands
Sanofi

Terminated

Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)

Warm Autoimmune Hemolytic Anemia (wAIHA)

United Kingdom, Belgium, Netherlands, France, United States, Germany, Hungary, Italy
Agios Pharmaceuticals, Inc.

Terminated

Pyruvate Kinase (PK) Deficiency Global Longitudinal Registry: Patient-Reported Outcomes (PRO) (PKD)

Anemia | Anemia, Hemolytic | Pyruvate Kinase Deficiency | Pyruvate Kinase Deficiency Anemia

United States, United Kingdom, Italy, Spain, Netherlands
Radboud University Medical Center

Completed

The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria (PREPARE)

Paroxysmal Nocturnal Hemoglobinuria | Eculizumab | PK-PD

Netherlands
Skyline Diagnostics BV
Illumina, Inc.

Terminated

Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler

Acute Myeloid Leukemia (AML) | Acute Promyelocytic Leukemia (APL) | Refractory Anemia With Excess of Blasts (RAEB)

United States, Germany, Netherlands, United Kingdom
Stichting Hemato-Oncologie voor Volwassenen Nederland

Not yet recruiting

Zanubrutinib in Primary Cold Agglutinin Disease (HOVON169CAD)

Lymphoma

Norway, Netherlands, Denmark, Belgium
Sanquin Research & Blood Bank Divisions
Erasmus Medical Center

Completed

Well Being of Obstetric Patients on Minimal Blood Transfusions (WOMB)

Anemia

Netherlands
AKARI Therapeutics
Radboud University Medical Center

Completed

Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH)

Paroxysmal Nocturnal Haemoglobinuria (PNH)

Netherlands
European Society for Blood and Marrow Transplantation
Novartis; Pfizer

Completed

hATG+CsA vs hATG+CsA+Eltrombopag for SAA (RACE)

Severe Aplastic Anemia

Switzerland, Netherlands, France, Italy, Spain, United Kingdom
Alexion

Completed

Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS (aHUS)

Atypical Hemolytic Uremic Syndrome

Canada, United Kingdom, France, Germany, Netherlands, Sweden, Italy
Alexion Pharmaceuticals

Completed

Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS) (aHUS)

Atypical Hemolytic Uremic Syndrome

Canada, United Kingdom, France, Germany, Sweden, Netherlands, Italy
Sangart

Withdrawn

Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis

Sickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | Hemoglobin SC Disease | Sickle Cell Disorders | Sickle Cell Hemoglobin C Disease

France, United Kingdom, Netherlands, Turkey, Bahrain, Belgium, Brazil, Lebanon, Qatar
Modus Therapeutics AB
Ergomed

Completed

Sevuparin Infusion for the Management of Acute VOC in Subjects With SCD

Sickle-Cell Disease

Netherlands, Oman, Jamaica, Lebanon, Bahrain, Saudi Arabia, Turkey
CSL Behring

Completed

Safety of Single Doses of CSL889 in Adult Patients With Sickle Cell Disease

Sickle Cell Disease

United States, United Kingdom, Netherlands
Pfizer

Completed

Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Study Of PF-04447943, Co-Administered With And Without Hydroxyurea, In Subjects With Stable Sickle Cell Disease

Phase 1 Sickle Cell

United States, United Kingdom, Belgium, Netherlands, Italy
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion...
Erasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaborators

Terminated

Insufficient Cellular Oxygen in ICU Patients With Anaemia (INOX ICU-2)

Anemia | Critical Care | Erythrocyte Transfusion | Oxygen | Mitochondria

Netherlands

Clinical Trials on Anemia Ferropenic in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations